Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThrogmorton Trust Regulatory News (THRG)

  • This share is currently suspended. It was suspended at a price of 552.00
  • There is currently no data for THRG

Issue of Equity

12 May 2021 18:29

BlackRock Throgmorton Trust Plc - Issue of Equity

BlackRock Throgmorton Trust Plc - Issue of Equity

PR Newswire

London, May 12

BlackRock Throgmorton Trust plc (“Company”)

LEI - 5493003B7ETS1JEDPF59

Issue of Equity

The Company announces that 70,000 Ordinary shares of 5p each were today issued by the Company at a price of 861.95 pence per share which represented a premium to net asset value. The new Ordinary shares will rank pari passu with the existing shares and trade on the London Stock Exchange's main market for listed securities. This allotment of new shares is being made to satisfy market demand and is made under the Company’s annual issuance authority and from its existing general purpose block listing.

The number of ordinary shares that the Company has in issue following this issue, is 93,140,389 (ordinary shares held in treasury: nil). With effect from 14 May 2021 the total number of voting rights of the Company will be 93,140,389. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure Guidance and Transparency Rules. 

Following this share issue, 7,210,423 ordinary shares remain under the issuance authority granted at the last Annual General Meeting held on 24 March 2021.

Contact name for queries:

Kevin Maygerfor and on behalf of BlackRock Investment Management (UK) Limited, Company SecretaryTel: 020 7743 1098

12 May 2021

Date   Source Headline
1st May 20253:50 pmPRNDisclosure of Portfolio Holdings
1st May 202511:42 amPRNNet Asset Value(s)
1st May 20257:00 amPRNTotal Voting Rights
30th Apr 202511:36 amPRNNet Asset Value(s)
30th Apr 20257:00 amPRNTotal Voting Rights
29th Apr 202511:22 amPRNNet Asset Value(s)
29th Apr 202510:18 amPRNHolding(s) in Company
28th Apr 20255:43 pmPRNTransaction in Own Shares
28th Apr 20254:16 pmPRNPortfolio Update
28th Apr 202511:45 amPRNNet Asset Value(s)
28th Apr 20257:00 amPRNTotal Voting Rights
25th Apr 20253:41 pmPRNDirector/PDMR Shareholding
25th Apr 20253:39 pmPRNDirector/PDMR Shareholding
25th Apr 202512:10 pmPRNNet Asset Value(s)
25th Apr 20257:00 amPRNTotal Voting Rights
24th Apr 20255:28 pmPRNTransaction in Own Shares
24th Apr 202512:00 pmPRNNet Asset Value(s)
24th Apr 20259:10 amPRNDirector/PDMR Shareholding
24th Apr 20257:00 amPRNTotal Voting Rights
23rd Apr 20255:34 pmPRNTransaction in Own Shares
23rd Apr 20253:47 pmPRNDirector/PDMR Shareholding
23rd Apr 20251:04 pmPRNNet Asset Value(s)
22nd Apr 20255:47 pmPRNTransaction in Own Shares
22nd Apr 202512:13 pmPRNNet Asset Value(s)
22nd Apr 20257:00 amPRNTotal Voting Rights
17th Apr 202511:37 amPRNNet Asset Value(s)
17th Apr 20259:45 amRNS-RUpdate from QuotedData
16th Apr 20255:35 pmPRNTransaction in Own Shares
16th Apr 202512:02 pmPRNNet Asset Value(s)
16th Apr 20257:00 amPRNTotal Voting Rights
15th Apr 202512:14 pmPRNNet Asset Value(s)
15th Apr 20257:00 amPRNTotal Voting Rights
14th Apr 20255:32 pmPRNTransaction in Own Shares
14th Apr 20251:57 pmPRNDirector/PDMR Shareholding
14th Apr 202512:00 pmPRNNet Asset Value(s)
14th Apr 20257:00 amPRNTotal Voting Rights
11th Apr 20255:40 pmPRNTransaction in Own Shares
11th Apr 202512:23 pmPRNNet Asset Value(s)
10th Apr 20255:16 pmPRNTransaction in Own Shares
10th Apr 202512:53 pmPRNNet Asset Value(s)
10th Apr 20257:00 amPRNTotal Voting Rights
9th Apr 202511:48 amPRNNet Asset Value(s)
8th Apr 20255:40 pmPRNTransaction in Own Shares
8th Apr 202511:51 amPRNNet Asset Value(s)
8th Apr 20257:00 amPRNTotal Voting Rights
7th Apr 202512:21 pmPRNNet Asset Value(s)
7th Apr 20257:00 amPRNTotal Voting Rights
4th Apr 20255:21 pmPRNTransaction in Own Shares
4th Apr 202512:41 pmPRNNet Asset Value(s)
4th Apr 20257:00 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.